Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)

BACKGROUND: Serogroup B Neisseria meningitidis (MenB) has always been a major cause of invasive meningococcal disease (IMD) in Canada. With the successful implementation of a meningitis C conjugate vaccine, the majority of IMD in Canada is now caused by MenB.

Bibliographic Details
Main Authors: Raymond SW Tsang, Dennis KS Law, Rita R Gad, Tim Mailman, Gregory German, Robert Needle
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2015/393659
id doaj-c3b9a23a8ca448aea09971c46d646ff6
record_format Article
spelling doaj-c3b9a23a8ca448aea09971c46d646ff62021-07-02T04:12:35ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322015-01-0126629930410.1155/2015/393659Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)Raymond SW Tsang0Dennis KS Law1Rita R Gad2Tim Mailman3Gregory German4Robert Needle5National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, CanadaNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, CanadaCommunicable Disease Control Unit, Department of Health, Government of New Brunswick, Fredericton, New Brunswick, CanadaDepartment of Pathology and Laboratory Medicine, IWK Health Centre, Halifax, Nova Scotia, CanadaDepartment of Health, Government of Prince Edward Island, Charlottetown, Prince Edward Island, CanadaPublic Health Laboratory and Microbiology, Eastern Health, St John’s, Newfoundland and Labrador, CanadaBACKGROUND: Serogroup B Neisseria meningitidis (MenB) has always been a major cause of invasive meningococcal disease (IMD) in Canada. With the successful implementation of a meningitis C conjugate vaccine, the majority of IMD in Canada is now caused by MenB.http://dx.doi.org/10.1155/2015/393659
collection DOAJ
language English
format Article
sources DOAJ
author Raymond SW Tsang
Dennis KS Law
Rita R Gad
Tim Mailman
Gregory German
Robert Needle
spellingShingle Raymond SW Tsang
Dennis KS Law
Rita R Gad
Tim Mailman
Gregory German
Robert Needle
Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)
Canadian Journal of Infectious Diseases and Medical Microbiology
author_facet Raymond SW Tsang
Dennis KS Law
Rita R Gad
Tim Mailman
Gregory German
Robert Needle
author_sort Raymond SW Tsang
title Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)
title_short Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)
title_full Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)
title_fullStr Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)
title_full_unstemmed Characterization of Invasive Neisseria meningitidis from Atlantic Canada, 2009 To 2013: With Special Reference to the Nonpolysaccharide Vaccine Targets (Pora, Factor H Binding Protein, Neisseria Heparin-Binding Antigen and Neisseria Adhesin A)
title_sort characterization of invasive neisseria meningitidis from atlantic canada, 2009 to 2013: with special reference to the nonpolysaccharide vaccine targets (pora, factor h binding protein, neisseria heparin-binding antigen and neisseria adhesin a)
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases and Medical Microbiology
issn 1712-9532
publishDate 2015-01-01
description BACKGROUND: Serogroup B Neisseria meningitidis (MenB) has always been a major cause of invasive meningococcal disease (IMD) in Canada. With the successful implementation of a meningitis C conjugate vaccine, the majority of IMD in Canada is now caused by MenB.
url http://dx.doi.org/10.1155/2015/393659
work_keys_str_mv AT raymondswtsang characterizationofinvasiveneisseriameningitidisfromatlanticcanada2009to2013withspecialreferencetothenonpolysaccharidevaccinetargetsporafactorhbindingproteinneisseriaheparinbindingantigenandneisseriaadhesina
AT denniskslaw characterizationofinvasiveneisseriameningitidisfromatlanticcanada2009to2013withspecialreferencetothenonpolysaccharidevaccinetargetsporafactorhbindingproteinneisseriaheparinbindingantigenandneisseriaadhesina
AT ritargad characterizationofinvasiveneisseriameningitidisfromatlanticcanada2009to2013withspecialreferencetothenonpolysaccharidevaccinetargetsporafactorhbindingproteinneisseriaheparinbindingantigenandneisseriaadhesina
AT timmailman characterizationofinvasiveneisseriameningitidisfromatlanticcanada2009to2013withspecialreferencetothenonpolysaccharidevaccinetargetsporafactorhbindingproteinneisseriaheparinbindingantigenandneisseriaadhesina
AT gregorygerman characterizationofinvasiveneisseriameningitidisfromatlanticcanada2009to2013withspecialreferencetothenonpolysaccharidevaccinetargetsporafactorhbindingproteinneisseriaheparinbindingantigenandneisseriaadhesina
AT robertneedle characterizationofinvasiveneisseriameningitidisfromatlanticcanada2009to2013withspecialreferencetothenonpolysaccharidevaccinetargetsporafactorhbindingproteinneisseriaheparinbindingantigenandneisseriaadhesina
_version_ 1721340616313405440